Skip to main content
. 2026 Nov 2;14:1967139. doi: 10.3389/fped.2026.1967139

Table 2.

Covariate-adjusted linear regressions of maternal 25(OH)D3 concentrations categorized as quartiles and neurodevelopmental outcomes (N = 252).

Neurodevelopmental outcome measure Quartile Difference vs. Q1 (95% CI) p-value Overall F (df) Overall p-value Partial eta squared
WPPSI-IVCDN FSIQ – – – 2.96 (3, 201) 0.03* 0.04
Q1 Reference – – – –
Q2 11.79 (3.05, 20.5) 0.008 – – –
Q3 0.30 (−7.61, 8.21) 0.94 – – –
Q4 7.43 (−0.31, 15.17) 0.06 – – –
NEPSY-II Phonological Processing – – – 0.75 (3, 231) 0.53 0.01
Q1 Reference – – – –
Q2 −0.19 (−1.83, 1.45) 0.82 – – –
Q3 0.08 (−2.04, 2.19) 0.94 – – –
Q4 −1.40 (−3.40, 0.60) 0.17 – – –
NEPSY-II Speeded Naming – – – 0.53 (3, 153) 0.67 0.01
Q1 Reference – – – –
Q2 0.32 (−1.69, 2.33) 0.75 – – –
Q3 −0.57 (−2.65, 1.51) 0.59 – – –
Q4 0.12 (−1.70, 1.93) 0.90 – – –
MABC-II Total – – – 0.52 (3, 232) 0.67 0.01
Q1 Reference – – – –
Q2 0.22 (−1.30, 1.75) 0.78 – – –
Q3 −0.81 (−2.82, 1.19) 0.43 – – –
Q4 0.56 (−1.34, 2.45) 0.54 – – –
BASC-II Internalizing Problems – – – 0.75 (3, 175) 0.52 0.01
Q1 Reference – – – –
Q2 2.82 (−2.16, 7.79) 0.27 – – –
Q3 0.28 (−4.65, 5.21) 0.91 – – –
Q4 2.42 (−2.05, 6.89) 0.29 – – –
BASC-II Externalizing Problems – – – 0.80 (3, 201) 0.50 0.01
Q1 Reference – – – –
Q2 3.10 (−2.49, 8.69) 0.28 – – –
Q3 3.54 (−1.52, 8.60) 0.17 – – –
Q4 2.13 (−2.82, 7.08) 0.40 – – –

Covariates are the same as those included in the linear regressions of continuous maternal 25(OH)D3 concentrations and neurodevelopmental outcomes.

*p < 0.05.